Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

475 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC. Tam XH, et al. Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256. Clin Sci (Lond). 2011. PMID: 20726839
Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.
Tan KC, Chow WS, Ai VH, Lam KS. Tan KC, et al. Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6. doi: 10.1002/dmrr.255. Diabetes Metab Res Rev. 2002. PMID: 11921421 Clinical Trial.
Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.
Tan KC, O K, Chow WS, Ai VH, Siow YL, Lam KS. Tan KC, et al. Eur J Clin Invest. 2002 May;32(5):328-34. doi: 10.1046/j.1365-2362.2002.00990.x. Eur J Clin Invest. 2002. PMID: 12027872
Advanced glycation end products and endothelial dysfunction in type 2 diabetes.
Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114
475 results
Jump to page
Feedback